Wandering in dementia (WANDA) – a systematic review of interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use

Study Code / Acronym
WANDA
Award Number
03/16/04
Programme
Health Technology Assessment
Status / Stage
Completed
Dates
1 March 2004 -
1 April 2005
Duration (calculated)
01 years 01 months
Funder(s)
NIHR
Funding Amount
£124,900.00
Funder/Grant study page
NIHR
Contracted Centre
University of Newcastle upon Tyne
Principal Investigator
Professor Dame Louise Robinson
PI Contact
a.l.robinson@ncl.ac.uk
WHO Catergories
Risk reduction intervention
Tools and methodologies for interventions
Disease Type
Dementia (Unspecified)

CPEC Review Info
Reference ID57
ResearcherReside Team
Published12/06/2023

Data

Study Code / AcronymWANDA
Award Number03/16/04
Status / StageCompleted
Start Date20040301
End Date20050401
Duration (calculated) 01 years 01 months
Funder/Grant study pageNIHR
Contracted CentreUniversity of Newcastle upon Tyne
Funding Amount£124,900.00

Abstract

Wandering is a common problem in dementia occurring in up to 40% of people. The term ‘wandering’ refers to a complex collection of different behavioural abnormalities which occur for a multitude of reasons. Traditional responses to wandering include physical barriers (alarms, locks), human and physical restraints (Buxton chairs, tethers), and medication (neuroleptic). More recent interventions include electronic devices that increase freedom and autonomy while minimising risk (electronic tagging and tracking), behavioural approaches (such as cognitive behavioural therapy), and distraction therapies (such as physical activity and planned walks, music therapy, occupational therapy). Subjective barriers (visual modifications that the person with dementia may interpret as a barrier even if it is not physically so e.g. painted bars on windows), were the subject of a recent Cochrane review which found no suitable trials from which to comment on their effectiveness. A systematic review is therefore required to synthesise the evidence for the other non-pharmacological interventions listed above. This project aims to determine the clinical and cost effectiveness of non-drug related interventions to prevent/reduce wandering in people with dementia, and to assess their acceptability to relevant stakeholders, through a systematic review. If the available evidence on cost effectiveness is too limited or of unsatisfactory quality, the economic evaluation will include a simulation modelling exercise. Outcomes will include the number of successful/attempted exits, number and nature of accidents, acceptability measures for both patients and carers, quality of life measures and assessment of costs of care. The project will also consider in greater depth the acceptability and ethical implications of such interventions through a qualitative study of relevant stakeholders, such as people with dementia, their informal and formal carers and health and social care professionals via focus groups and one to one interviews.

Aims

This project aims to determine the clinical and cost effectiveness of non-drug related interventions to prevent/reduce wandering in people with dementia, and to assess their acceptability to relevant stakeholders, through a systematic review.